glp-1 obesity drug news oct 21 2025 Why drugs are changing the future of metabolic health New weight-loss drugs surge in
Description
Tirzepatide treatment duration Tirzepatide is designed for ongoing treatment
A GLP-1 receptor agonist is a medication that mimics the function of GLP-1 (glucagon-like peptide-1), which is a naturally occurring gut hormone
doi: 10.1016/j.obpill.2024.100136
The master complaint alleges that Novo Nordisk, Eli Lilly, and other manufacturers failed to provide adequate warnings about severe gastrointestinal risks
Karacabeyli D, Lacaille D
Dulaglutide: a novel once-weekly glucagon-like peptide-1 receptor agonist
